Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stargardt's disease
|
24 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Blindness
|
34 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.050 | 1.000 | 5 | 2005 | 2011 | ||||
Sudden sensorineural hearing loss
|
38 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Vascular Diseases
|
40 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1 | 2006 | 2006 | |||||
Atypical Hemolytic Uremic Syndrome
|
42 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Low Vision
|
51 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Retinal Diseases
|
56 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Lupus Nephritis
|
64 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Polypoidal choroidal vasculopathy
|
67 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.060 | 0.833 | 6 | 2008 | 2013 | ||||
exudative macular degeneration
|
69 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||
Geographic Atrophy
|
81 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.760 | 1.000 | 7 | 2006 | 2018 | ||||
Exudative age-related macular degeneration
|
109 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.800 | 0.950 | 20 | 2005 | 2018 | ||||
Septicemia
|
141 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.020 | 1.000 | 2 | 2010 | 2020 | ||||
Sepsis
|
144 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.020 | 1.000 | 2 | 2010 | 2020 | ||||
Chronic kidney disease stage 5
|
194 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Alzheimer Disease, Late Onset
|
243 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1 | 2007 | 2007 | |||||
Arteriosclerosis
|
267 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.030 | 1.000 | 3 | 2008 | 2012 | ||||
Glycogen storage disease type II
|
269 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.100 | 0.889 | 27 | 2006 | 2019 | ||||
Familial (FPAH)
|
276 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Atherosclerosis
|
281 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.030 | 1.000 | 3 | 2008 | 2012 | ||||
Pseudoxanthoma Elasticum
|
323 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1 | 2008 | 2008 | |||||
Impaired cognition
|
348 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Venous Thromboembolism
|
408 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1 | 2006 | 2006 | |||||
Kidney Failure, Chronic
|
425 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Coronary Arteriosclerosis
|
440 | 0.561 | 0.720 | 1 | 196690107 | missense variant | C/T | snv | 0.68 | 0.64 | 0.040 | 1.000 | 4 | 2006 | 2011 |